Valeur Intrinsèque du S&P et Nasdaq Contactez-nous
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Retour aux actions

CalciMedica, Inc. CALC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
38/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$266.00
+41783.2%

Il y a eu 50 transactions d'initiés récentes enregistrées pour CalciMedica, Inc. (CALC), dont 48 achats et 1 vente. Le total des achats d'initiés s'élève à $2.43M et le total des ventes d'initiés à $3.65K.

Les initiés notables ayant une activité récente comprennent Glicklich Alan, Roberts Eric W, Hebbar Sudarshan. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — CALC

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2025-10-13 Glicklich Alan Director Attribution de RSU 937 $3.26 $3.05K 937
2025-09-18 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 2,500 $3.07 $7.68K 84,150
2025-09-15 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 3,400 $2.68 $9.1K 81,650
2025-09-12 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 5,000 $3.12 $15.6K 78,250
2025-09-09 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 2,343 $3.15 $7.38K 73,250
2025-08-29 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 800 $2.74 $2.19K 70,907
2025-08-28 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 9,200 $2.86 $26.34K 70,107
2025-08-21 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 3,508 $2.79 $9.8K 60,907
2025-08-20 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 2,000 $2.72 $5.44K 57,399
2025-08-19 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 1,000 $2.79 $2.79K 55,399
2025-08-19 Hebbar Sudarshan Chief Medical Officer Achat Informatif 9,563 $2.82 $26.96K 61,539
2025-08-15 Hebbar Sudarshan Chief Medical Officer Achat Informatif 4,392 $2.79 $12.27K 51,976
2025-08-15 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 5,076 $2.90 $14.71K 54,399
2025-08-14 Hebbar Sudarshan Chief Medical Officer Achat Informatif 1,584 $2.59 $4.09K 47,584
2025-07-28 Stauderman Kenneth A. Chief Scientific Officer Achat Informatif 1,000 $3.96 $3.96K 12,944
2025-07-25 Stauderman Kenneth A. Chief Scientific Officer Vente Informative 1,000 $3.65 $3.65K -
2025-07-22 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 1,500 $3.78 $5.66K 49,323
2025-07-21 Leheny A. Rachel 10 Percent Owner, Officer: Chief Executive Officer Achat Informatif 1,000 $3.40 $3.4K 3,500
2025-07-21 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 1,500 $3.37 $5.06K 47,823
2025-07-18 Wilson Robert N Director Achat Informatif 4,500 $2.87 $12.92K 422,029
2025-07-18 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 2,000 $2.88 $5.76K 46,323
2025-07-14 Leheny A. Rachel 10 Percent Owner, Officer: Chief Executive Officer Achat Informatif 2,500 $2.47 $6.18K 2,500
2025-07-14 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 6,500 $2.43 $15.81K 44,323
2025-07-09 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 5,000 $1.60 $8.02K 37,823
2025-07-01 Stauderman Kenneth A. Chief Scientific Officer Achat Informatif 1,000 $1.85 $1.85K 1,000
2025-06-26 Bardin Stephen Chief Financial Officer Achat Informatif 2,000 $1.50 $3.01K 3,000
2025-06-26 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 4,500 $1.44 $6.48K 32,823
2025-06-24 Wilson Robert N Director Attribution de RSU 10,000 $1.65 $16.5K 10,000
2025-06-24 Middleton Fred A 10 Percent Owner Attribution de RSU 6,562 $1.53 $10.04K 6,562
2025-06-24 Leheny A. Rachel 10 Percent Owner, Officer: Chief Executive Officer Attribution de RSU 77,625 $1.53 $118.77K 77,625
2025-06-24 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Attribution de RSU 72,750 $1.53 $111.31K 72,750
2025-06-24 Shaw Allan Director Attribution de RSU 8,594 $1.53 $13.15K 8,594
2025-06-24 Glicklich Alan Director Attribution de RSU 4,166 $1.53 $6.37K 4,166
2025-06-24 Guerard Frederic Director Attribution de RSU 5,000 $1.53 $7.65K 5,000
2025-06-24 Bardin Stephen Chief Financial Officer Attribution de RSU 20,000 $1.53 $30.6K 20,000
2025-06-24 Dunn Michael J. President and COO Attribution de RSU 47,125 $1.53 $72.1K 47,125
2025-06-24 Hebbar Sudarshan Chief Medical Officer Attribution de RSU 83,300 $1.53 $127.45K 83,300
2025-06-24 Stauderman Kenneth A. Chief Scientific Officer Attribution de RSU 47,125 $1.53 $72.1K 47,125
2025-06-11 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 5,000 $1.85 $9.25K 28,323
2025-06-06 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 5,000 $1.78 $8.88K 23,323
2025-06-05 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Achat Informatif 5,100 $1.70 $8.67K 18,323
2025-05-30 Bardin Stephen Chief Financial Officer Achat Informatif 1,000 $1.69 $1.69K 41,000
2025-04-23 Leheny A. Rachel 10 Percent Owner, Officer: Chief Executive Officer Attribution de RSU 285,000 $1.53 $436.05K 285,000
2025-04-23 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Attribution de RSU 160,000 $1.53 $244.8K 160,000
2025-04-23 Bardin Stephen Chief Financial Officer Attribution de RSU 130,000 $1.53 $198.9K 130,000
2025-04-23 Dunn Michael J. President and COO Attribution de RSU 125,000 $1.53 $191.25K 125,000
2025-04-23 Hebbar Sudarshan Chief Medical Officer Attribution de RSU 175,000 $1.53 $267.75K 175,000
2025-04-23 Stauderman Kenneth A. Chief Scientific Officer Attribution de RSU 125,000 $1.53 $191.25K 125,000
2025-01-15 Glicklich Alan Officer Inconnu - - - -
2025-01-15 Glicklich Alan Director Attribution de RSU 20,000 $3.02 $60.4K 20,000
■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration

Les autres consultent aussi

PDSB
PDSB
PDS Biotechnology Corporation
$1.36
+28.30%
 MAIA
MAIA
MAIA Biotechnology, Inc.
$1.42
+3.65%
 ELUT
ELUT
Elutia Inc.
$1.17
+2.63%
 XLO
XLO
Xilio Therapeutics, Inc.
$8.61
+0.23%
 LVTX
LVTX
LAVA Therapeutics N.V.
$1.74
-3.87%
 ATNM
ATNM
Actinium Pharmaceuticals, Inc.
$1.26
+14.55%
 RNXT
RNXT
RenovoRx, Inc.
$1.02
-0.97%
 TVRD
TVRD
Tvardi Therapeutics, Inc.
$3.47
+9.81%
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
📧 [email protected]
📞 +65 8912 8000
Envoyez-nous un message